| (SEK) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 199.89M | — |
| Operating expense | — | — |
| Net income | 32.63M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, CEVI.ST returned -5.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +8.9% |
| 1 year | -5.8% |
| 5 years | -61.1% |
| 10 years | +139.3% |
| All-time high | kr 458.00 (Aug 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what kr1,000 in CEVI.ST would be worth today ›Yes. CellaVision AB (publ) paid 1 dividend over the past 12 months. The most recent was kr 2.75 per share on Apr 29, 2026. The dividend yield is 1.68%.
CellaVision AB (publ) is part of the Healthcare sector.
CellaVision AB (publ) has a market cap of 3.99B SEK, based on the latest quote.
CellaVision AB (publ) is expected to report earnings around Oct 28, 2026. That date is an estimate and has not been confirmed by the company.